FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Reiterates Buy Opinion On Shares Of Us Foods Holding Corp.

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target to by $11 to $109, based on 21x our 2027 EPS (unchanged), a premium to shares' 19x ten-year average forward multiple, justified by an improved operating margin profile. We lower our 2026 EPS to $4.55 from $4.78 and 2027's to $5.17 from $5.71, reflecting pressure on distribution costs (+3.9% in Q1) from fuel expenses and ongoing softness in chain restaurant case volumes (-2.3% in Q1). Following Q1 results, we reiterate our Buy opinion. Softer case volumes (+1.4%), below the 1.8% consensus estimate, were primarily fueled by 1.1% organic case growth, a sign that demand remains intact. The company highlighted momentum accelerated heading into Q2. Additionally, independent restaurant volumes (+4.6%) accelerated for the fourth consecutive quarter, highlighting traction with higher-margin customers. Technologies like Menu IQ, along with the expansion of small-truck deliveries, represent inroads to the independent restaurant industry and support our view of expanding EBITDA margins in 2026 and 2027.

Related Articles

Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Exelon Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $2 to $48, 16.8x our next-12-month EPS estimate of $2.88, slightly above its five-year average of 16.4x. We lower our 2026 EPS view by $0.08 to $2.85 and lower 2027 EPS by $0.06 to $3.04. In our opinion, EXC now faces significant regulatory headwinds in Pennsylvania and Maryland. PECO's withdrawal of its rate case in April 2026 amid affordability concerns and Governor scrutiny creates uncertainty around timing and terms of future Pennsylvania filings, while Maryland's Utility RELIEF Act (awaiting Governor signature) prohibits forecast test years until April 2027 and constrains ratemaking tools for BGE, Pepco, and DPL. Despite these headwinds, EXC maintained its long-term (2025-2029) EPS growth guidance range of 5%-7% and expects to deliver near the top end of that range. From 2025 to 2028, we project EPS growth at a 5.6% CAGR, slightly below the midpoint of the range and below our expectations for peers, while we anticipate dividend growth close to a 5.1% CAGR, closer to peers.

$EXC
Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Exelon Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $2 to $48, 16.8x our next-12-month EPS estimate of $2.88, slightly above its five-year average of 16.4x. We lower our 2026 EPS view by $0.08 to $2.85 and lower 2027 EPS by $0.06 to $3.04. In our opinion, EXC now faces significant regulatory headwinds in Pennsylvania and Maryland. PECO's withdrawal of its rate case in April 2026 amid affordability concerns and Governor scrutiny creates uncertainty around timing and terms of future Pennsylvania filings, while Maryland's Utility RELIEF Act (awaiting Governor signature) prohibits forecast test years until April 2027 and constrains ratemaking tools for BGE, Pepco, and DPL. Despite these headwinds, EXC maintained its long-term (2025-2029) EPS growth guidance range of 5%-7% and expects to deliver near the top end of that range. From 2025 to 2028, we project EPS growth at a 5.6% CAGR, slightly below the midpoint of the range and below our expectations for peers, while we anticipate dividend growth close to a 5.1% CAGR, closer to peers.

$EXC
Research

Research Alert: CFRA Keeps Hold Rating On Shares Of Block, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $10 to $81, 16.7x our 2027 earnings estimate, vs. XYZ's three-year historical forward P/E average of 25.4x. We raise our 2026 EPS view to $3.85 from $3.62 and 2027's to $4.85 from $4.35. Following a strong first quarter, XYZ significantly raised its full-year 2026 guidance, and is now projecting 19% gross profit growth and over 60% growth in adjusted EPS. This confidence is fueled by accelerating momentum across its core businesses, including explosive growth in Cash App's lending products and renewed strength in Square's target verticals. Crucially, the quarter provided the first tangible proof of its AI-centric strategy, with management citing a 2.5x increase in engineer productivity and dramatically accelerated project timelines. While the 82% surge in lending originations introduces heightened credit risk, this is currently being managed by a disciplined underwriting model where loss rates on mature customer cohorts are proving to be healthy and predictable.

$XYZ